Exelixis | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Bayer EUR 1.83B 2.31B 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Eisai JPY -21000000 29.57B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Exelixis USD 205.69M 20.92M 2025-03
Genmab DKK 244M 3.36B 2025-03
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 234.19M 172.64M 2025-03
Ionis Pharmaceuticals USD -147000000 40M 2025-03
MacroGenics USD -14477000 70.79M 2024-12
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Takeda JPY -107299000000 133.71B 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Xencor USD -52626000 6.33M 2024-12



Exelixis Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.